Accenture plc (ACN) Stock Forecast
Data as of May 2, 2026Technology · Current price $179.19 (+0.27%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 14, 2026 | Jason Kupferberg | Wells Fargo | $275.00 | +53.5% |
| Dec 19, 2025 | Kevin McVeigh | UBS | $320.00 | +78.6% |
| Dec 18, 2025 | Keith Bachman | BMO Capital | $300.00 | +67.4% |
| Dec 18, 2025 | Daniel Perlin | RBC Capital | $295.00 | +64.6% |
| Dec 18, 2025 | James Schneider | Goldman Sachs | $330.00 | +84.2% |
| Oct 21, 2025 | Jason Kupferberg | Wells Fargo | $251.00 | +40.1% |
| Sep 26, 2025 | David Koning | Robert W. Baird | $330.00 | +84.2% |
| Sep 24, 2025 | Kevin McVeigh | UBS | $315.00 | +75.8% |
| Dec 20, 2024 | Surinder Thind | Jefferies | $385.00 | +114.9% |
| Dec 19, 2024 | James Schneider | Goldman Sachs | $430.00 | +140.0% |
| Dec 19, 2024 | David Grossman | Stifel Nicolaus | $390.00 | +117.6% |
| Nov 5, 2024 | David Koning | Robert W. Baird | $370.00 | +106.5% |
| Oct 30, 2024 | Stefan Slowinski | BNP Paribas | $375.00 | +109.3% |
| Sep 30, 2024 | Bryan Bergin | TD Securities | $400.00 | +123.2% |
| Sep 27, 2024 | James Friedman | Susquehanna | $360.00 | +100.9% |
| Sep 27, 2024 | Jonathan Lee | Guggenheim | $395.00 | +120.4% |
| Sep 27, 2024 | James Faucette | Morgan Stanley | $335.00 | +87.0% |
| Sep 26, 2024 | David Grossman | Stifel Nicolaus | $375.00 | +109.3% |
| Sep 26, 2024 | Arvind Ramnani | Piper Sandler | $395.00 | +120.4% |
| Sep 25, 2024 | Keith Bachman | BMO Capital | $380.00 | +112.1% |
Top Analysts Covering ACN
ACN vs Sector & Market
| Metric | ACN | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.22 | 2.34 | 2.41 |
| Analyst Count | 18 | 13 | 18 |
| Target Upside | +67.4% | +4072.6% | +14.9% |
| P/E Ratio | 14.68 | 27.92 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-31 | $73.41B | $74.12B | $74.42B | 20 |
| 2026-11-28 | $19.41B | $19.67B | $19.91B | 6 |
| 2027-02-28 | $18.75B | $19.01B | $19.23B | 8 |
| 2027-05-28 | $19.48B | $19.75B | $19.99B | 8 |
| 2027-08-28 | $19.26B | $19.53B | $19.76B | 8 |
| 2027-08-31 | $76.31B | $78.03B | $78.93B | 21 |
| 2027-11-28 | $20.55B | $20.83B | $21.08B | 8 |
| 2028-02-28 | $19.80B | $20.07B | $20.32B | 5 |
| 2028-05-28 | $20.38B | $20.66B | $20.91B | 5 |
| 2028-08-28 | $20.49B | $20.77B | $21.02B | 5 |
| 2028-08-31 | $82.84B | $82.93B | $83.02B | 17 |
| 2029-08-31 | $89.90B | $91.62B | $92.47B | 8 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-31 | $13.66 | $13.88 | $14.16 | 16 |
| 2026-11-28 | $3.98 | $4.05 | $4.12 | 6 |
| 2027-02-28 | $3.19 | $3.25 | $3.30 | 6 |
| 2027-05-28 | $3.98 | $4.06 | $4.12 | 11 |
| 2027-08-28 | $3.56 | $3.63 | $3.69 | 6 |
| 2027-08-31 | $14.65 | $14.95 | $15.21 | 18 |
| 2027-11-28 | $4.30 | $4.37 | $4.44 | 9 |
| 2028-02-28 | $3.50 | $3.57 | $3.62 | 10 |
| 2028-05-28 | $4.32 | $4.40 | $4.46 | 7 |
| 2028-08-28 | $3.91 | $3.98 | $4.05 | 8 |
| 2028-08-31 | $14.88 | $16.25 | $17.19 | 9 |
| 2029-08-31 | $17.84 | $18.28 | $18.50 | 6 |
Frequently Asked Questions
What is the analyst consensus for ACN?
The consensus among 18 analysts covering Accenture plc (ACN) is Buy with an average price target of $299.92.
What is the highest price target for ACN?
The highest price target for ACN is $475.00, set by James Faucette at Morgan Stanley on 2022-03-26.
What is the lowest price target for ACN?
The lowest price target for ACN is $175.00, set by Arvind Ramnani at Piper Sandler on 2023-06-23.
How many analysts cover ACN?
18 analysts have issued ratings for Accenture plc in the past 12 months.
Is ACN a buy or sell right now?
Based on 18 analyst ratings, ACN has a consensus rating of Buy (2.22/5) with a +67.4% upside to the consensus target of $299.92.
What are the earnings estimates for ACN?
Analysts estimate ACN will report EPS of $13.88 for the period ending 2026-08-31, with revenue estimated at $74.12B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.